Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31


EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

Ocheni S, Kroeger N, Zabelina T, Sobottka I, Ayuk F, Wolschke C, Muth A, Lellek H, Petersen L, Erttmann R, Kabisch H, Zander AR, Bacher U.

Bone Marrow Transplant. 2008 Aug;42(3):181-6. doi: 10.1038/bmt.2008.150. Epub 2008 Jun 2.


Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease.

Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S.

Cancer Sci. 2008 Jun;99(6):1085-91. doi: 10.1111/j.1349-7006.2008.00813.x. Epub 2008 Apr 21. Review.


Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.

Brown JA, Boussiotis VA.

Clin Immunol. 2008 Jun;127(3):286-97. doi: 10.1016/j.clim.2008.02.008. Epub 2008 Apr 18. Review.


T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.

Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC, Perales MA, Collins N, Cisek C, Chiu M, van den Brink MR, O'Reilly RJ, Papadopoulos EB.

Blood. 2007 Dec 15;110(13):4552-9. Epub 2007 Aug 23.


Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.

Capello D, Rossi D, Gaidano G.

Hematol Oncol. 2005 Jun;23(2):61-7. Review.


Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M.

Bone Marrow Transplant. 2004 Oct;34(8):721-7.


Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients.

Orentas RJ, Schauer DW Jr, Ellis FW, Walczak J, Casper JT, Margolis DA.

Pediatr Transplant. 2003 Aug;7(4):305-14.


High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

Juvonen E, Aalto SM, Tarkkanen J, Volin L, Mattila PS, Knuutila S, Ruutu T, Hedman K.

Bone Marrow Transplant. 2003 Jul;32(1):97-102.


Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.

Deeg HJ, Shulman HM, Anderson JE, Bryant EM, Gooley TA, Slattery JT, Anasetti C, Fefer A, Storb R, Appelbaum FR.

Blood. 2000 Feb 15;95(4):1188-94.


Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ.

Blood. 1999 Oct 1;94(7):2208-16.


Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Gooley TA, Leisenring W, Crowley J, Storer BE.

Stat Med. 1999 Mar 30;18(6):695-706. Review.


B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.

Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK, Wagner JE, Filipovich AH.

Bone Marrow Transplant. 1999 Feb;23(3):251-8. Review.


Immunodeficiency-associated lymphoproliferative disorders.

Knowles DM.

Mod Pathol. 1999 Feb;12(2):200-17. Review.


Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.

Micallef IN, Chhanabhai M, Gascoyne RD, Shepherd JD, Fung HC, Nantel SH, Toze CL, Klingemann HG, Sutherland HJ, Hogge DE, Nevill TJ, Le A, Barnett MJ.

Bone Marrow Transplant. 1998 Nov;22(10):981-7.


Malignancies after hematopoietic stem cell transplantation: many questions, some answers.

Deeg HJ, Socie G.

Blood. 1998 Mar 15;91(6):1833-44. Review. No abstract available.


T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW.

Blood. 1998 Feb 1;91(3):1083-90.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk